News & Updates
Showing Pharmacy articles
Showing
Pain mechanisms tied to disease activity in DMARD-treated RA
A recent study has shown the importance of identifying and treating aberrant peripheral and central pain regulation in patients with rheumatoid arthritis (RA) who are either initiating or switching to disease-modifying antirheumatic drug (DMARD) treatment.
Pain mechanisms tied to disease activity in DMARD-treated RA
15 Jun 2023
BNT162b2 booster protects against COVID-19 infection, hospitalization in adolescents
In a national cohort study in Singapore, a booster dose of BNT162b2 maintained individual protection against severe COVID-19 disease among adolescents aged 12–17 years.
BNT162b2 booster protects against COVID-19 infection, hospitalization in adolescents
13 Jun 2023
Post-treatment HBsAg loss greater with TDF vs entecavir
In patients with chronic hepatitis B (CHB) without cirrhosis, the rates of hepatitis B surface antigen (HBsAg) loss appear to be higher after discontinuation of tenofovir disoproxil fumarate (TDF) than of entecavir, and this is particularly true for patients who have not experienced relapse after treatment discontinuation, according to a study.